ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Additional Resources

PKD Research Resource Consortium Annual Symposium

September 13 - September 14, 2022

Location: Virtual

Details: https://www.scgcorp.com/PKDRRC2022/

Polycystic kidney diseases (PKD) comprise a group of renal cystic disorders that are accompanied by a broad array of extrarenal manifestations. These disorders are a major cause of morbidity in adults and children. Autosomal dominant PKD is the most common single gene disorder that results in end-stage kidney disease. Autosomal recessive PKD is rare but more severe, resulting in perinatal mortality in 30–40 percent of affected infants. Although the most common causative genes for PKD (PKD1, PKD2, and PKHD1) were identified more than 2 decades ago, we still lack effective therapies, and major questions remain in our understanding of disease pathogenesis. The PKD RRC seeks to address these gaps by creating a collaborative framework that develops and shares research resources to support innovation in PKD research.

Trainee Abstract Deadline: August 22
Registration Deadline: September 8

Learn more: https://www.scgcorp.com/PKDRRC2022/Default